Levofloxacin Unimed Pharma (Levofloxacin Hemihydrate)

Levofloxacin exerts its antibacterial effect by inhibiting two essential bacterial enzymes, DNA gyrase (topoisomerase II) and topoisomerase IV. Blocking these enzymes prevents DNA replication and transcription, leading to rapid bacterial cell death and clearance of the infection.

The dosing regimen for Levofloxacin ophthalmic solution is determined by the prescribing clinician based on the type and severity of the eye infection, the patient’s age, and other clinical factors. Typical regimens involve one to two drops per eye several times daily for a defined treatment period.

Safety data for levofloxacin use during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Levofloxacin offers broad‑spectrum activity against both Gram‑negative and Gram‑positive ocular pathogens and has excellent corneal penetration. Compared with older agents such as ciprofloxacin, it often requires fewer daily doses and may have a lower risk of resistance development, though choice of therapy should be guided by local susceptibility patterns.

Store the ophthalmic solution at room temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight and extreme temperatures. Keep the vial tightly closed when not in use and discard any solution that appears discolored or cloudy.

The solution is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac without touching the tip of the bottle to the eye or surrounding tissues. Close the eye gently for a few seconds to allow distribution.

Serious adverse events, although rare, include corneal ulceration, severe allergic reactions such as anaphylaxis, and sudden loss of visual acuity. Patients should seek immediate medical attention if they experience persistent eye pain, worsening redness, vision changes, or signs of a systemic allergic response.

Individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation should avoid this product. It is also contraindicated for viral, fungal, or non‑bacterial eye infections, and should be used with caution in patients with pre‑existing corneal disorders or those taking interacting systemic medications.